Watch

COAGHemab Therapeutics Holdings, In

Healthcare · Biotechnology · small-cap ($1.9B)
-25.6%
from rolling 252-day high of $55.42 set 2026-08-14 · 35d ago
Current
$41.19
Decline depth
-25.6%
Decline σ
5.8σ
TFC
0/5 bearish

Where it stands

On the Watch.

Down 25.6% from its rolling 252-day high, 35 days after the high.

Snapshot . Price structure, not a judgment about the business.

What changed

Since the previous observation.

Tier and recovery signal are unchanged between these two observations.

Comparing with . This compares classification, not price returns.

See the recorded timeline →

Why it is flagged

COAG qualifies for the Watch on decline depth.

Down 25.6% from its rolling 252-day high, 35 days after the high. The most severe triggered rule determines the tier.

Inspect the three classification measures
Decline depth
-25.6%
From rolling 252-day high of $55.42, 35d ago. Past the 20% Watch threshold.
Time-frame continuity
0/5 bearish
Latest bar on five time frames, daily to yearly. Bearish = 2-Down or red 3.
Decline sigma
5.8σ
Drop over the last 20 bars in units of daily volatility (3.93%/day). Past the ≥4σ Watch threshold.

Price history

The price path behind the snapshot.

Daily prices with the rolling-high reference. When a recorded classification event falls on a displayed trading date, it is marked on the chart.

Rolling 252-day high Gold dots: recorded classification events (see timeline) Up day Down day 90 daily bars from Alpaca · through

The recorded history

A timeline of observations.

First observed 2026-09-09. These are scan observations, not exact transition times or the start of a decline. Missing scan dates are not filled in.

  1. Amber List → Watch
  2. First observed: Amber List

Absence from a captured list does not establish recovery. Historical tiers reflect the rules and data recorded at that time.

Technical interpretation and signal details

The structural read

What price action says about COAG.

COAG qualifies for the Watch on decline depth — down -25.6% from its rolling 252-day high.

Cross-confirmation: decline sigma also reads 5.8σ over 20 bars.

Earnings on file: 2026-08-11. Earnings dates don't affect tiering.

Questions about COAG

What people ask.

Why is COAG on Broken Stocks?

COAG qualifies for the Watch on decline depth. It is down -25.6% from its rolling 252-day high of $55.42, set on 2026-08-14 — 35d ago.

Is COAG a falling knife?

No. The falling-knife label usually implies a steep, severe drop — typically 30% or more from a fresh high. COAG is down -25.6% from its 52-week high, which qualifies for the Watch tier but is shallower than the falling-knife pattern. It's an early-stage decline rather than a sharp breakdown.

Is COAG a buy?

Broken Stocks does not issue buy or sell recommendations. The list is a rules-based technical warning system. It tracks structural decline depth and recency — not company quality, management, fundamentals, or news. Always do your own research and consult a licensed advisor.

Where is COAG trading inside its 52-week range?

At $41.19, COAG sits 56.1% of the way from its 52-week low ($23.00) to its 52-week high ($55.42). A reading below 25% indicates price is hugging the bottom of the range; above 75%, the top.

How fast has COAG been declining?

The current 25.6% decline accrued over 35d, which annualizes to roughly -267.0% per year. Annualized pace is a sanity check — a 30% decline in three months is a different signal than a 30% decline over two years.

How does COAG compare to its sector?

There are 344 other Healthcare tickers on Broken Stocks: 199 Red, 87 Amber, 58 Watch, with 168 showing recovering structural signals. Median sector decline is -36.5% — COAG's decline is shallower than the sector median.

Does COAG's earnings date affect its tier?

No. Tiering uses decline depth and recency, bearish time-frame structure, and decline sigma. The earnings date on file (2026-08-11) is shown for reference only — listings can move tier between scans based on closing prices, regardless of fundamentals or news events.